
Over the last 7 days, the Clinical Research and Equipment industry has remained flat, although notably Locus Cell gained 23%. The past year has been better, since the industry has gained 8.7% in that time.
Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Apr 2026 | NT$39.6b | NT$2.5b | -NT$764,028,000.00 | 22x | -51.8x | 15.7x |
| Fri, 27 Mar 2026 | NT$31.5b | NT$2.5b | -NT$747,966,000.00 | 20.4x | -42.1x | 12.5x |
| Sun, 22 Feb 2026 | NT$33.3b | NT$2.4b | -NT$689,929,000.00 | 23.8x | -48.3x | 13.7x |
| Tue, 20 Jan 2026 | NT$35.0b | NT$2.4b | -NT$689,929,000.00 | 24.9x | -50.7x | 14.4x |
| Thu, 18 Dec 2025 | NT$34.4b | NT$2.4b | -NT$670,921,000.00 | 22.6x | -51.3x | 14.1x |
| Sat, 15 Nov 2025 | NT$40.2b | NT$2.5b | -NT$871,098,000.00 | 18.6x | -46.2x | 16.3x |
| Mon, 13 Oct 2025 | NT$38.0b | NT$2.5b | -NT$870,437,000.00 | 19x | -43.6x | 15.5x |
| Wed, 10 Sep 2025 | NT$35.8b | NT$2.5b | -NT$819,216,000.00 | 20.4x | -43.8x | 14.6x |
| Fri, 08 Aug 2025 | NT$33.0b | NT$2.5b | -NT$600,003,000.00 | 21.1x | -55.1x | 13.4x |
| Sun, 06 Jul 2025 | NT$33.5b | NT$2.5b | -NT$600,003,000.00 | 23.1x | -55.8x | 13.6x |
| Tue, 03 Jun 2025 | NT$33.3b | NT$2.5b | -NT$600,003,000.00 | 22.4x | -55.4x | 13.5x |
| Thu, 01 May 2025 | NT$32.0b | NT$2.5b | -NT$540,128,000.00 | 24x | -59.2x | 13x |
| Sat, 29 Mar 2025 | NT$36.1b | NT$2.4b | -NT$560,979,000.00 | 28.9x | -64.4x | 15x |
| Mon, 24 Feb 2025 | NT$37.4b | NT$2.6b | -NT$854,432,000.00 | 24.3x | -43.8x | 14.6x |
| Wed, 22 Jan 2025 | NT$35.5b | NT$2.6b | -NT$854,432,000.00 | 23.3x | -41.6x | 13.9x |
| Fri, 20 Dec 2024 | NT$34.9b | NT$2.6b | -NT$854,432,000.00 | 24.5x | -40.9x | 13.6x |
| Sun, 17 Nov 2024 | NT$40.7b | NT$2.5b | -NT$856,799,000.00 | 24x | -47.5x | 16x |
| Tue, 15 Oct 2024 | NT$40.7b | NT$2.3b | -NT$836,610,000.00 | 22.1x | -48.7x | 17.9x |
| Thu, 12 Sep 2024 | NT$40.4b | NT$2.3b | -NT$836,610,000.00 | 21.4x | -48.3x | 17.8x |
| Sat, 10 Aug 2024 | NT$39.3b | NT$2.1b | -NT$791,513,000.00 | 27.9x | -49.7x | 18.5x |
| Mon, 08 Jul 2024 | NT$44.7b | NT$2.1b | -NT$797,765,000.00 | 34.5x | -56.1x | 21x |
| Wed, 05 Jun 2024 | NT$40.7b | NT$2.1b | -NT$797,765,000.00 | 33.7x | -51x | 19.1x |
| Fri, 03 May 2024 | NT$39.9b | NT$2.1b | -NT$914,899,000.00 | 32.4x | -43.7x | 18.8x |
| Sun, 31 Mar 2024 | NT$40.3b | NT$2.1b | -NT$903,875,000.00 | 31.7x | -44.6x | 19.1x |
| Tue, 27 Feb 2024 | NT$44.7b | NT$2.1b | -NT$610,218,000.00 | 34x | -73.3x | 21.5x |
| Thu, 25 Jan 2024 | NT$44.9b | NT$2.1b | -NT$610,218,000.00 | 33.9x | -73.6x | 21.6x |
| Sat, 23 Dec 2023 | NT$47.2b | NT$2.1b | -NT$610,218,000.00 | 33.5x | -77.3x | 22.7x |
| Mon, 20 Nov 2023 | NT$48.9b | NT$2.1b | -NT$609,632,000.00 | 31x | -80.1x | 23.5x |
| Wed, 18 Oct 2023 | NT$47.6b | NT$2.2b | -NT$497,769,000.00 | 31.1x | -95.6x | 21.4x |
| Fri, 15 Sep 2023 | NT$43.6b | NT$2.2b | -NT$497,769,000.00 | 31x | -87.5x | 19.6x |
| Sun, 13 Aug 2023 | NT$43.9b | NT$2.2b | -NT$485,875,000.00 | 42.6x | -90.4x | 19.6x |
| Tue, 11 Jul 2023 | NT$48.3b | NT$2.5b | -NT$274,767,000.00 | 42.6x | -175.8x | 19.7x |
| Thu, 08 Jun 2023 | NT$49.6b | NT$2.5b | -NT$274,767,000.00 | 42.9x | -180.6x | 20.2x |
| Sat, 06 May 2023 | NT$53.0b | NT$2.7b | -NT$29,017,000.00 | 24.4x | -1826.6x | 19.9x |
-1826.6x
How does Taiwanese Clinical Research and Equipment compare with similar industries?
| TW Market | 4.31% | |
| Healthcare | -3.66% | |
| Life Sciences | 7.94% | |
| Clinical Research and Equipment | 7.94% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6891 Locus Cell | NT$89.00 | 36.1% +NT$4.7b | 304.5% | PS1397.7x | |
| 6939 TFBS Bioscience | NT$24.45 | 20.7% +NT$146.7m | -3.7% | n/a | |
| 7837 Creative Life Science | NT$110.50 | 4.2% +NT$100.6m | n/a | n/a | |
| 7607 DuoGenic StemCells | NT$15.35 | 5.5% +NT$24.4m | 5.1% | n/a |